Rupert Davies is an accomplished professional in the field of translational medicine and clinical pharmacology, currently serving as Executive Director of Translational Medicine at InduPro since May 2025. Prior to this, Rupert held similar executive roles at Vertex Pharmaceuticals and Alpine Immune Sciences, Inc. Rupert's extensive experience includes senior positions at Zymeworks Inc., Amgen, and Sarepta Therapeutics, where contributions spanned various aspects of drug development and pharmacokinetics. An academic background includes a Post-doctorate in Bioengineering from the University of Washington and a PhD in Bioengineering from the University of Utah, complemented by a Bachelor of Science in Civil and Environmental Engineering from the University of Michigan.
This person is not in any teams
This person is not in any offices